Ferroptosis and WDFY4 as novel targets for immunotherapy of lung adenocarcinoma

Author:

Huang Ling123,Zhong Lifan3,Cheng Ruxin4,Chang Limei2,Qin Mingyan2,Liang Huaping1,Liao Zhongkai5

Affiliation:

1. State Key Laboratory of Trauma, Burns and Combined Injury, Department of Wound Infection and Drug, Daping Hospital, Army Medical University, Chongqing, China

2. Hainan Center for Drug and Medical Device Evaluation and Service, Hainan Medical Products Administration, Haikou, China

3. School of Hainan Provincial Drug Safety Evaluation Research Center, Hainan Medical University, Haikou, China

4. Emergency and Trauma College, Hainan Medical University, Haikou, Hainan, China

5. Department of Thoracic Surgery, The Second Affiliated Hospital of Hainan Medical University, Haikou, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference35 articles.

1. World Health Organization. Cancer Today. Accessed 16 June, 2022. http://www.who.int/news-room/fact-sheets/detail/cancer.

2. The biology and management of non-small cell lung cancer.;Boshoff;Nature,2018

3. Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review.;Riely;JAMA,2019

4. Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.;Golding;N Engl J Med,2017

5. The immune contexture in cancer prognosis and treatment.;Kroemer;Nat Rev Clin Oncol,2017

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3